Predictive Oncology Inc (POAI)
1.01
-0.01
(-0.98%)
USD |
NASDAQ |
Jul 03, 16:00
Predictive Oncology Cash from Investing (Quarterly): -0.003M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.003M |
| December 31, 2023 | 0.0073M |
| September 30, 2023 | -0.0039M |
| June 30, 2023 | -0.2591M |
| March 31, 2023 | -0.0466M |
| December 31, 2022 | -0.0636M |
| September 30, 2022 | -0.1437M |
| June 30, 2022 | -0.1882M |
| March 31, 2022 | -0.0802M |
| December 31, 2021 | -9.787M |
| September 30, 2021 | -0.1865M |
| June 30, 2021 | -0.2407M |
| March 31, 2021 | -0.3931M |
| December 31, 2020 | -0.1413M |
| September 30, 2020 | -0.1162M |
| June 30, 2020 | 0.1225M |
| March 31, 2020 | -0.0325M |
| December 31, 2019 | -0.0073M |
| September 30, 2019 | -0.0108M |
| June 30, 2019 | 0.0437M |
| March 31, 2019 | -0.6247M |
| December 31, 2018 | -1.014M |
| September 30, 2018 | -0.1411M |
| June 30, 2018 | -0.1007M |
| March 31, 2018 | 0.1456M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0229M |
| September 30, 2017 | 0.6724M |
| June 30, 2017 | -0.012M |
| March 31, 2017 | -2.336M |
| December 31, 2016 | 0.1808M |
| September 30, 2016 | 0.9711M |
| June 30, 2016 | 0.244M |
| March 31, 2016 | -1.819M |
| December 31, 2015 | -0.0368M |
| September 30, 2015 | -0.016M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.0077M |
| December 31, 2014 | 0.0011M |
| September 30, 2014 | -0.0351M |
| June 30, 2014 | -0.0006M |
| March 31, 2014 | -0.0866M |
| December 31, 2013 | -0.1143M |
| September 30, 2013 | -0.0435M |
| June 30, 2013 | -0.0584M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-9.787M
Minimum
Dec 2021
0.1225M
Maximum
Jun 2020
-0.6092M
Average
-0.0802M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| icad Inc | -0.206M |
| Perspective Therapeutics Inc | -47.30M |
| Semler Scientific Inc | -0.081M |
| Xtant Medical Holdings Inc | -0.674M |
| Asensus Surgical Inc | 3.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.416M |
| Cash from Financing (Quarterly) | -0.1124M |
| Free Cash Flow | -13.44M |
| Free Cash Flow Per Share (Quarterly) | -0.8415 |
| Free Cash Flow to Equity (Quarterly) | -3.307M |
| Free Cash Flow Yield | -329.4% |